Viral Hepatitis Recommendations for Solid-Organ Transplant Recipients and Donors

Transplantation. 2018 Feb;102(2S Suppl 2):S66-S71. doi: 10.1097/TP.0000000000002013.

Authors

Luciana Costa Faria¹, Débora Raquel Benedita Terrabuio², Hakan Leblebicioglu³, Shirish Huprikar⁴

Affiliations

¹ Department of Internal Medicine of Faculdade de Medicina da Universidade Federal de Minas Gerais. Gastroenterology Alfa Institute, Hospital das Clínicas da Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
² Department of Gastroenterology, University of São Paulo, Shcool of Medicine, Brazil.
³ Department of Infectious Diseases and Clinical Microbiology, Ondokuz Mayis University Medical School, Samsun, Turkey.
⁴ Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY USA.

PMID: 29381580
DOI: 10.1097/TP.0000000000002013

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Antiviral Agents / adverse effects
Antiviral Agents / therapeutic use*
Donor Selection / methods*
Donor Selection / standards
Hepatitis, Viral, Human / diagnosis
Hepatitis, Viral, Human / drug therapy*
Hepatitis, Viral, Human / transmission
Hepatitis, Viral, Human / virology
Host-Pathogen Interactions
Humans
Immunocompromised Host
Immunosuppressive Agents / adverse effects
Latin America
Organ Transplantation / adverse effects
Organ Transplantation / methods*
Organ Transplantation / standards
Practice Guidelines as Topic
Risk Assessment
Risk Factors
Tissue Donors*
Transplant Recipients*
Travel-Related Illness*
Treatment Outcome

Substances

Antiviral Agents
Immunosuppressive Agents